Funded Tech Companies
Vicebio
Headquartered in London, Vicebio has funding from Uniquest of Korea, venBio and Medicxi Ventures.
Company Overview
Company Name
Vicebio
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
2nd Floor 168 Shoreditch High Street
London, E1 6RA
UK
London, E1 6RA
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
We were founded to develop the patented Molecular Clamp technology invented at The University of Queensland, Australia and exclusively licensed to Vicebio by UniQuest, the commercialisation company of UQ. The Molecular Clamp technology stabilises viral glycoproteins in "pre-fusion" conformation, to deliver highly protective and ready-to-use fully liquid vaccines.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/23/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Emmanuel Hanon
Chief Medical Officer
Giovanni Cioppa
Chief Scientific Officer
Keith Chappell
Chief Technical Officer
Jean Smal
VP - Bus. Development
Juana Magdalena
VP - Regulatory Affairs
Koen Huygens
VP - Regulatory Affairs
Frank Vandendriessche
Company Investors
- Uniquest of Korea
- venBio
- Medicxi Ventures
- Avoro Ventures
- TCGX
- Goldman Sachs
Browse more funded tech companies:
Vice Media | Vicept Therapeutics
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs